Rath Lukas, Jokisch Friedrich, Schulz Gerald Bastian, Kretschmer Alexander, Buchner Alexander, Stief Christian G, Weinhold Philipp
Department of Urology, Ludwig-Maximilians-University, Munich, Germany.
Res Rep Urol. 2021 Nov 23;13:815-821. doi: 10.2147/RRU.S341823. eCollection 2021.
There are only a few case reports and case series that investigated combined laparoscopic or robotic surgery for simultaneous prostate and kidney cancer. In this study, we want to close a gap in existing research to assess the feasibility and oncological outcome of combined open prostatectomy and kidney surgery.
We retrospectively analyzed patients who underwent a combined open prostatectomy and either a partial or complete nephrectomy from 2013 to 2020. Descriptive statistics were used to assess perioperative parameters and the 12-month functional and oncological outcomes after combined surgery.
We identified 10 patients undergoing combined open surgery. Partial nephrectomy was performed in 4, radical nephrectomy in 6 patients. For prostate cancer, histopathological analysis showed a tumor stage ≥ pT2c in all 10 patients. For renal tumors, histopathological analysis showed clear cell renal cell carcinoma in 8 patients and oncocytoma in 2 patients. Operating time was 177 ± 36 minutes. Two perioperative complications (Clavien 2a and 3) were observed. Three months postoperatively, the International Index of Erectile Function (IIEF-5) score was 5.6 ± 5.9, the ICIQ-SF score was 7.3 ± 5.6 and were using 1.9 ± 2.2 pads per day. This improved after 12 months postoperatively, as patients had an IIEF-5 score of 6.33 ± 6.5, an ICIQ-SF score of 4.4 ± 5.7 and were using pads 0.9 ± 1.7 per day.
In this study, we showed that open surgery is a safe and valid approach for combined prostatectomy and renal surgery with acceptable complications and oncological outcomes. The combined open approach could be a good alternative to combined laparoscopic/robotic surgery in this field, especially to treat patients with advanced renal tumors or previous abdominal surgery or radiation.
仅有少数病例报告和病例系列研究了联合腹腔镜或机器人手术同时治疗前列腺癌和肾癌。在本研究中,我们希望填补现有研究的空白,以评估开放性前列腺切除术与肾脏手术联合的可行性及肿瘤学结局。
我们回顾性分析了2013年至2020年期间接受开放性前列腺切除术联合部分或全肾切除术的患者。采用描述性统计来评估围手术期参数以及联合手术后12个月的功能和肿瘤学结局。
我们确定了10例接受联合开放性手术的患者。4例行部分肾切除术,6例行根治性肾切除术。对于前列腺癌,组织病理学分析显示所有10例患者的肿瘤分期≥pT2c。对于肾肿瘤,组织病理学分析显示8例为透明细胞肾细胞癌,2例为嗜酸细胞瘤。手术时间为177±36分钟。观察到2例围手术期并发症(Clavien 2a和3级)。术后3个月,国际勃起功能指数(IIEF-5)评分为5.6±5.9,ICIQ-SF评分为7.3±5.6,每天使用1.9±2.2片尿垫。术后12个月有所改善,患者的IIEF-5评分为6.33±6.5,ICIQ-SF评分为4.4±5.7,每天使用尿垫0.9±1.7片。
在本研究中,我们表明开放性手术是前列腺切除术与肾脏手术联合的一种安全有效的方法,并发症和肿瘤学结局均可接受。在该领域,联合开放性手术方法可能是联合腹腔镜/机器人手术的一个良好替代方案,尤其是对于治疗晚期肾肿瘤患者或既往有腹部手术或放疗史的患者。